Effect of frequently used chemotherapeutic drugs on the cytotoxic activity of human natural killer cells.

Markasz, L. and Stuber, G. and Vanherberghen, B. and Flaberg, E. and Oláh, Éva (2007) Effect of frequently used chemotherapeutic drugs on the cytotoxic activity of human natural killer cells. MOLECULAR CANCER THERAPEUTICS, 6 (2). pp. 644-654. ISSN 1535-7163

Text 1235272.pdf Restricted to Registered users only Download (348kB) | Request a copy

Abstract

Tumors are considered to be possible targets of immunotherapy using stimulated and expanded autologous or allogeneic natural killer (NK) cells mismatched for MHC class I molecules and inhibitory NK receptors. NK cell-based immunoadjuvant therapies are carried out in combination with standard chemotherapeutic protocols. In the presented study, we characterized the effect of 28 frequently used chemotherapeutic agents on the capacity of NK cells to kill target cells. We found that treatment of NK cells with the drugs vinblastine, paclitaxel, docetaxel, cladribine, chlorambucil, bortezomib, and MG-132 effectively inhibited NK cell-mediated killing without affecting the viability of NK cells. On the other hand, the following drugs permitted efficient NK cell-mediated killing even at concentrations comparable with or higher than the maximally achieved therapeutic concentration in vivo in humans: asparaginase, bevacizumab, bleomycin, doxorubicin, epirubicin, etoposide, 5-fluorouracil, hydroxyurea, streptozocin, and 6-mercaptopurine.

Actions (login required)

Edit Item